Integrated Phenotypic and Genotypic Approaches for Accurate Diagnosis of G6PD Deficiency: Implications for Drug Safety in Thailand

Documenti analoghi

• Upadacitinib‐Induced Hemolysis in a Patient With Glucose‐6‐Phosphate Dehydrogenase Deficiency—A Possible Adverse Drug Reaction
  di: Laura Patanè, et al.
  Pubblicazione: (2025)
• Assessment of Potential Drug–Drug Interactions for Novel Oral Melanocortin‐1 Receptor Agonist Dersimelagon
  di: Akihito Ogasawara, et al.
  Pubblicazione: (2025)
• Assessments of CYP‐Inhibition‐Based Drug–Drug Interactions Between Tofacitinib and Lipid‐Lowering Agents in Rats Both In Vitro and In Vivo
  di: Hang Yang, et al.
  Pubblicazione: (2025)
• Phenotype versus genotype to optimize cancer dosing in the clinical setting—focus on 5‐fluorouracil and tyrosine kinase inhibitors
  di: Jennifer H. Martin, et al.
  Pubblicazione: (2024)
• Carbohydrate‐Rich Fraction of Aloe vera (L.) Burm.f. Extract Mitigates Bone Loss and Improves Metabolic Disturbance in Estrogen‐Deficient Rats
  di: Panan Suntornsaratoon, et al.
  Pubblicazione: (2025)